NPs Basic Information

Name
Ophiobolin I
Molecular Formula C25H36O3
IUPAC Name*
(1'R,2S,3S,3'S,5R,7'R,8'E,11'R)-8'-(hydroxymethyl)-1',3,4'-trimethyl-5-(2-methylprop-1-enyl)spiro[oxolane-2,12'-tricyclo[9.3.0.03,7]tetradeca-4,8-diene]-6'-one
SMILES
C[C@H]1C[C@@H](O[C@@]12CC[C@]3([C@H]2C/C=C(\[C@H]4[C@H](C3)C(=CC4=O)C)/CO)C)C=C(C)C
InChI
InChI=1S/C25H36O3/c1-15(2)10-19-12-17(4)25(28-19)9-8-24(5)13-20-16(3)11-21(27)23(20)18(14-26)6-7-22(24)25/h6,10-11,17,19-20,22-23,26H,7-9,12-14H2,1-5H3/b18-6-/t17-,19-,20+,22+,23-,24+,25-/m0/s1
InChIKey
PWHAYWTWJLFKJT-MUKMEUIDSA-N
Synonyms
Ophiobolin I; 110013-85-9; CHEMBL469706
CAS NA
PubChem CID 14035917
ChEMBL ID CHEMBL469706
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Sesterterpenoids
          • Direct Parent: Ophiobolane sesterterpeno

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 384.6 ALogp: 3.9
HBD: 1 HBA: 3
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 46.5 Aromatic Rings: 4
Heavy Atoms: 28 QED Weighted: 0.653

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.75 MDCK Permeability: 0.00001920
Pgp-inhibitor: 0.973 Pgp-substrate: 0.011
Human Intestinal Absorption (HIA): 0.034 20% Bioavailability (F20%): 0.787
30% Bioavailability (F30%): 0.874

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.979 Plasma Protein Binding (PPB): 79.51%
Volume Distribution (VD): 2.169 Fu: 6.64%

ADMET: Metabolism

CYP1A2-inhibitor: 0.024 CYP1A2-substrate: 0.572
CYP2C19-inhibitor: 0.073 CYP2C19-substrate: 0.807
CYP2C9-inhibitor: 0.064 CYP2C9-substrate: 0.054
CYP2D6-inhibitor: 0.02 CYP2D6-substrate: 0.143
CYP3A4-inhibitor: 0.927 CYP3A4-substrate: 0.535

ADMET: Excretion

Clearance (CL): 14.925 Half-life (T1/2): 0.082

ADMET: Toxicity

hERG Blockers: 0.021 Human Hepatotoxicity (H-HT): 0.927
Drug-inuced Liver Injury (DILI): 0.276 AMES Toxicity: 0.029
Rat Oral Acute Toxicity: 0.367 Maximum Recommended Daily Dose: 0.827
Skin Sensitization: 0.821 Carcinogencity: 0.122
Eye Corrosion: 0.101 Eye Irritation: 0.112
Respiratory Toxicity: 0.967
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC004222 0.847 D0E9KA 0.282
ENC001559 0.576 D06AEO 0.276
ENC003209 0.554 D04SFH 0.261
ENC005803 0.525 D0D2TN 0.261
ENC005044 0.457 D0V2JK 0.258
ENC005045 0.444 D08PIQ 0.250
ENC005046 0.417 D0I2SD 0.250
ENC003251 0.398 D04GJN 0.250
ENC002982 0.387 D0W2EK 0.248
ENC002981 0.348 D0Y2YP 0.248
*Note: the compound similarity was calculated by RDKIT.